• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

孕激素在前列腺癌治疗中的应用

Gestagens in the management of prostatic carcinoma.

作者信息

Szendröi Z

出版信息

Int Urol Nephrol. 1984;16(4):327-35. doi: 10.1007/BF02081869.

DOI:10.1007/BF02081869
PMID:6100181
Abstract

Two different hormonal gestagens, cyproterone acetate and norethisterone, were studied in prostatic carcinoma, for the greatest part in advanced cases. Cyproterone acetate was administered to 80, norethisterone to 38 unselected patients. The period of study extended over 2 years or more. The mechanism of action of gestagens and the role of the hormone receptors are discussed. The significance of serial measurements of plasma testosterone by providing a monitor of hormonal therapy is emphasized. The relevant literature is reviewed. The value of gestagens as an alternative to the traditional hormone therapy of prostatic carcinoma is pointed out.

摘要

在前列腺癌患者中,尤其是晚期患者,对两种不同的激素性孕激素——醋酸环丙孕酮和炔诺酮进行了研究。80例患者使用醋酸环丙孕酮,38例未经挑选的患者使用炔诺酮。研究期超过2年。文中讨论了孕激素的作用机制以及激素受体的作用。强调了通过连续测量血浆睾酮为激素治疗提供监测的重要性。回顾了相关文献。指出了孕激素作为前列腺癌传统激素治疗替代方法的价值。

相似文献

1
Gestagens in the management of prostatic carcinoma.孕激素在前列腺癌治疗中的应用
Int Urol Nephrol. 1984;16(4):327-35. doi: 10.1007/BF02081869.
2
[Therapy of virginal prostatic cancer with cyproterone acetate].
Z Urol Nephrol. 1985 Apr;78(4):181-7.
3
The effects of orchidectomy, estrogens, and cyproterone acetate on plasma testosterone, LH, and FSH concentrations in patients with carcinoma of the prostate.睾丸切除术、雌激素和醋酸环丙孕酮对前列腺癌患者血浆睾酮、促黄体生成素和促卵泡激素浓度的影响。
Scand J Urol Nephrol. 1982;16(1):31-6. doi: 10.3109/00365598209179637.
4
The position of cyproterone acetate (CPA), a steroidal anti-androgen, in the treatment of prostate cancer.醋酸环丙孕酮(CPA),一种甾体类抗雄激素药物,在前列腺癌治疗中的地位。
Prostate Suppl. 1992;4:91-5. doi: 10.1002/pros.2990210514.
5
The combination of cyproterone acetate and low dose diethylstilbestrol in the treatment of advanced prostatic carcinoma.
J Urol. 1988 Dec;140(6):1460-5. doi: 10.1016/s0022-5347(17)42073-8.
6
Decrease of serum testosterone by cyproterone acetate accompanied by an unexpected increase of calcitonin secretion capacity.醋酸环丙孕酮使血清睾酮水平降低,同时降钙素分泌能力意外增加。
J Urol. 1987 Aug;138(2):324-5. doi: 10.1016/s0022-5347(17)43135-1.
7
[Cancers of the prostate and cyproterone acetate. Value of blood testosterone and PSA levels for treatment surveillance].[前列腺癌与醋酸环丙孕酮。血液睾酮和前列腺特异性抗原水平在治疗监测中的价值]
J Urol (Paris). 1990;96(8):431-5.
8
Hormonal therapy of advanced prostatic cancer.晚期前列腺癌的激素治疗
J Urol. 1986 Sep;136(3):653-4. doi: 10.1016/s0022-5347(17)45005-1.
9
Cyproterone acetate, testosterone, LH, FSH, and prolactin levels in plasma after intramuscular application of cyproterone acetate in patients with prostatic cancer.前列腺癌患者肌肉注射醋酸环丙孕酮后血浆中醋酸环丙孕酮、睾酮、促黄体生成素、促卵泡生成素和催乳素水平
Prostate. 1981;2(3):315-22. doi: 10.1002/pros.2990020310.
10
Cyproterone acetate as monotherapy in prospective randomized trials.醋酸环丙孕酮在前瞻性随机试验中作为单一疗法。
Prog Clin Biol Res. 1990;359:85-91; discussion 105-7.

本文引用的文献

1
TREATMENT OF BENIGN PROSTATIC HYPERTROPHY WITH HYDROXYPROGESTERONE CAPROATE: EFFECT ON CLINICAL SYMPTOMS, MORPHOLOGY, AND ENDOCRINE FUNCTION.
JAMA. 1965 Jul 12;193:121-8. doi: 10.1001/jama.1965.03090020035009.
2
[Trial of prostatic cancer treatment with estrogens associated with cyproterone].[雌激素联合环丙孕酮治疗前列腺癌的试验]
Acta Urol Belg. 1980 Jan;48(1):110-2.
3
Effect of progestational agents on carcinoma of the prostate.孕激素制剂对前列腺癌的影响。
Cancer Chemother Rep. 1967 Feb;51(1):41-6.
4
A new oral progestational steroid effective in treating prostatic cancer.
Trans Am Assoc Genitourin Surg. 1966;58:54-62.
5
Cyproterone acetate (SH 714) effect on histology and nucleic acid synthesis in the testes of patients with prostatic carcinoma. A preliminary report.醋酸环丙孕酮(SH 714)对前列腺癌患者睾丸组织学及核酸合成的影响。初步报告。
Invest Urol. 1969 May;6(6):638-49.
6
Receptor proteins for androgens. On the role of specific proteins in selective retention of 17-beta-hydroxy-5-alpha-androstan-3-one by rat ventral prostate in vivo and in vitro.雄激素受体蛋白。关于特定蛋白质在大鼠腹侧前列腺体内外选择性保留17-β-羟基-5-α-雄甾烷-3-酮中的作用。
J Biol Chem. 1969 Dec 25;244(24):6584-95.
7
[The metabolism of norethisterone (17 -ethinyl-4-estren-17 -ol-3-one) and of DL- and D-norgestrel (18-methyl-17 -ethinyl-4-estren-17 -ol-3-one) in man. (Alkyl-substituted steroids. 8)].炔诺酮(17α-乙炔基-4-雌甾烯-17β-醇-3-酮)以及消旋-18-甲基炔诺酮和右旋-18-甲基炔诺酮(18-甲基-17α-乙炔基-4-雌甾烯-17β-醇-3-酮)在人体中的代谢。(烷基取代甾体。8)
Acta Endocrinol (Copenh). 1971 Oct;68(2):219-48.
8
[3 months contraception with norethisteronönantate. Clinical and biochemical studies].[炔诺酮庚酸酯的3个月避孕效果。临床与生化研究]
Med Welt. 1971 Oct 2;40:1551-3.
9
Mechanism of androgenic action: effect of specific intracellular inhibitors.雄激素作用机制:特定细胞内抑制剂的作用
J Urol. 1971 Jun;105(6):850-7. doi: 10.1016/s0022-5347(17)61645-8.
10
Plasma testosterone levels in patients with prostatic carcinoma before and after treatment.前列腺癌患者治疗前后的血浆睾酮水平。
J Urol. 1968 Jun;99(6):788-92. doi: 10.1016/S0022-5347(17)62795-2.